GSK agrees China hepatitis B deal as kicks off last tranche of buyback
(Alliance News) - GSK PLC on Monday launched the fifth tranche of its GBP2.0 billion buyback as it announced an exclusive collaboration with China pharmaceutical group Sino Biopharmaceutical Ltd. Read More